Acadia Healthcare (NASDAQ:ACHC – Get Rating) issued an update on its FY 2022 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $2.85-$3.15 for the period, compared to the consensus earnings per share estimate of $2.97. The company issued revenue guidance of $2.55 billion-$2.60 billion, compared to the consensus revenue estimate of $2.58 billion.
Shares of ACHC stock traded up $1.28 during mid-day trading on Thursday, reaching $67.65. 597,070 shares of the company were exchanged, compared to its average volume of 605,306. Acadia Healthcare has a fifty-two week low of $50.07 and a fifty-two week high of $76.69. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.22 and a current ratio of 1.29. The company has a market capitalization of $6.12 billion, a P/E ratio of 24.95, a P/E/G ratio of 2.31 and a beta of 1.28. The business’s 50 day simple moving average is $68.11 and its 200 day simple moving average is $61.26.
Acadia Healthcare (NASDAQ:ACHC – Get Rating) last announced its quarterly earnings results on Tuesday, May 3rd. The company reported $0.67 EPS for the quarter, beating the consensus estimate of $0.64 by $0.03. Acadia Healthcare had a return on equity of 10.16% and a net margin of 10.16%. The business had revenue of $616.65 million during the quarter, compared to analysts’ expectations of $606.49 million. During the same quarter in the previous year, the business posted $0.47 EPS. The firm’s quarterly revenue was up 11.9% compared to the same quarter last year. On average, analysts forecast that Acadia Healthcare will post 3.08 EPS for the current year.
Hedge funds have recently bought and sold shares of the business. BlackRock Inc. lifted its holdings in shares of Acadia Healthcare by 3.5% in the 4th quarter. BlackRock Inc. now owns 7,588,129 shares of the company’s stock valued at $460,597,000 after acquiring an additional 259,180 shares during the last quarter. Goldman Sachs Group Inc. lifted its position in Acadia Healthcare by 22.1% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,331,746 shares of the company’s stock valued at $80,836,000 after purchasing an additional 240,932 shares during the period. Morgan Stanley lifted its position in Acadia Healthcare by 251.1% during the second quarter. Morgan Stanley now owns 196,080 shares of the company’s stock valued at $12,305,000 after purchasing an additional 140,231 shares during the period. Renaissance Technologies LLC purchased a new position in Acadia Healthcare in the fourth quarter valued at $2,653,000. Finally, Wells Fargo & Company MN increased its stake in shares of Acadia Healthcare by 38.1% during the fourth quarter. Wells Fargo & Company MN now owns 73,892 shares of the company’s stock worth $4,486,000 after purchasing an additional 20,398 shares in the last quarter. Hedge funds and other institutional investors own 99.66% of the company’s stock.
About Acadia Healthcare (Get Rating)
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico.
- Get a free copy of the StockNews.com research report on Acadia Healthcare (ACHC)
- Carvana Insiders Buy Shares But Maybe You Shouldn’t
- Dutch Bros Gets Scalded By Inflation
- The S&P 500 Could Fall Another 28%
- Corning Stock is a Technology Value Play
- Anheuser-Busch InBev May Need One More Quarter to Confirm a Buy Signal
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.